Legal & General Group Plc Buys 192,818 Shares of GE HealthCare Technologies Inc. $GEHC

Legal & General Group Plc grew its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 7.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,900,935 shares of the company’s stock after purchasing an additional 192,818 shares during the quarter. Legal & General Group Plc’s holdings in GE HealthCare Technologies were worth $217,860,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Wedge Capital Management L L P NC bought a new position in shares of GE HealthCare Technologies during the third quarter valued at about $26,859,000. Valicenti Advisory Services Inc. grew its stake in shares of GE HealthCare Technologies by 22.6% in the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after purchasing an additional 12,550 shares during the last quarter. Locust Wood Capital Advisers LLC grew its stake in shares of GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after purchasing an additional 137,992 shares during the last quarter. Nan Fung Trinity HK Ltd. purchased a new position in GE HealthCare Technologies during the 3rd quarter valued at about $23,206,000. Finally, Envestnet Asset Management Inc. increased its holdings in GE HealthCare Technologies by 15.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after purchasing an additional 46,231 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on GEHC shares. Evercore increased their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Morgan Stanley boosted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 4th. Bank of America upped their target price on GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a report on Monday, January 5th. Wall Street Zen raised GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Finally, Wells Fargo & Company lifted their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Seven analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $92.17.

GE HealthCare Technologies Trading Down 3.2%

GE HealthCare Technologies stock opened at $70.33 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $89.77. The company has a market capitalization of $32.05 billion, a price-to-earnings ratio of 15.42, a price-to-earnings-growth ratio of 1.60 and a beta of 1.03. The business’s fifty day simple moving average is $81.02 and its two-hundred day simple moving average is $78.51. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s revenue was up 7.1% on a year-over-year basis. During the same period last year, the company earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.